Yatin Suneja
Stock Analyst at Guggenheim
(4.94)
# 162
Out of 4,690 analysts
437
Total ratings
56.6%
Success rate
30.3%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics | Reiterated: Buy | $130 | $104.09 | +24.89% | 7 | Aug 27, 2026 | |
| CABA Cabaletta Bio | Reiterated: Buy | $16 | $2.85 | +461.40% | 10 | Aug 14, 2026 | |
| ZBIO Zenas BioPharma | Reiterated: Buy | $55 | $31.29 | +75.78% | 4 | Aug 14, 2026 | |
| ALMS Alumis | Reiterated: Buy | $34 | $25.55 | +33.07% | 6 | Aug 14, 2026 | |
| IMUX Immunic | Reiterated: Buy | $70 | $15.93 | +339.42% | 2 | Aug 11, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $15 → $20 | $5.78 | +246.02% | 7 | Aug 11, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $200 | $107.40 | +86.22% | 7 | Aug 10, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $260 → $275 | $214.66 | +28.11% | 26 | Aug 10, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $6.25 | - | 9 | Aug 10, 2026 | |
| ROIV Roivant Sciences | Maintained: Buy | $36 → $42 | $36.16 | +16.15% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $14.39 | +143.22% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $44.87 | +122.87% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $65.26 | +37.91% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $19.55 | +145.52% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $800 | $386.33 | +107.08% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $12.89 | +249.11% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $112.41 | +77.92% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1,135 → $1,185 | $876.00 | +35.27% | 26 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,000 → $1,030 | $797.99 | +29.07% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $222 | $156.49 | +41.86% | 14 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $22 | $9.17 | +139.91% | 17 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 → $280 | $208.87 | +34.05% | 28 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $14.14 | +260.68% | 7 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $76.78 | -2.32% | 3 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $125.52 | +39.42% | 10 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $13.53 | +402.59% | 9 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $62 | $42.60 | +45.54% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $3.80 | +294.74% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.01 | +596.52% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $32.97 | +81.98% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.71 | +718.71% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 → $100 | $8.26 | +1,110.65% | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $56.98 | +145.70% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $17.23 | +16.08% | 11 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $36.74 | - | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $4.37 | +494.97% | 11 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $29.45 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $45 | $24.19 | n/a | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.37 | n/a | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.72 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.06 | n/a | 10 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $16.76 | n/a | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.30 | n/a | 2 | May 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $123 | $34.21 | n/a | 7 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $0.9215 | n/a | 1 | Jul 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $32 | $16.43 | n/a | 4 | Dec 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $49.50 | n/a | 6 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.71 | n/a | 1 | Aug 13, 2014 |
Spyre Therapeutics
Aug 27, 2026
Reiterated: Buy
Price Target: $130
Current: $104.09
Upside: +24.89%
Cabaletta Bio
Aug 14, 2026
Reiterated: Buy
Price Target: $16
Current: $2.85
Upside: +461.40%
Zenas BioPharma
Aug 14, 2026
Reiterated: Buy
Price Target: $55
Current: $31.29
Upside: +75.78%
Alumis
Aug 14, 2026
Reiterated: Buy
Price Target: $34
Current: $25.55
Upside: +33.07%
Immunic
Aug 11, 2026
Reiterated: Buy
Price Target: $70
Current: $15.93
Upside: +339.42%
Zura Bio
Aug 11, 2026
Reiterated: Buy
Price Target: $15 → $20
Current: $5.78
Upside: +246.02%
Oruka Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $200
Current: $107.40
Upside: +86.22%
Axsome Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $260 → $275
Current: $214.66
Upside: +28.11%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.25
Upside: -
Roivant Sciences
Aug 7, 2026
Maintained: Buy
Price Target: $36 → $42
Current: $36.16
Upside: +16.15%
Aug 7, 2026
Reiterated: Buy
Price Target: $35
Current: $14.39
Upside: +143.22%
Aug 6, 2026
Reiterated: Buy
Price Target: $100
Current: $44.87
Upside: +122.87%
Aug 6, 2026
Reiterated: Buy
Price Target: $90
Current: $65.26
Upside: +37.91%
Aug 6, 2026
Reiterated: Buy
Price Target: $50 → $48
Current: $19.55
Upside: +145.52%
Aug 6, 2026
Reiterated: Buy
Price Target: $800
Current: $386.33
Upside: +107.08%
Aug 6, 2026
Maintained: Buy
Price Target: $45
Current: $12.89
Upside: +249.11%
Aug 5, 2026
Reiterated: Buy
Price Target: $200
Current: $112.41
Upside: +77.92%
Aug 4, 2026
Initiated Coverage: Buy
Price Target: $1,135 → $1,185
Current: $876.00
Upside: +35.27%
Aug 3, 2026
Maintained: Buy
Price Target: $1,000 → $1,030
Current: $797.99
Upside: +29.07%
Jul 31, 2026
Maintained: Buy
Price Target: $200 → $222
Current: $156.49
Upside: +41.86%
Jul 31, 2026
Maintained: Buy
Price Target: $25 → $22
Current: $9.17
Upside: +139.91%
Jul 21, 2026
Rated: Buy
Price Target: $260 → $280
Current: $208.87
Upside: +34.05%
Jul 17, 2026
Reiterated: Buy
Price Target: $51
Current: $14.14
Upside: +260.68%
Jul 9, 2026
Reiterated: Buy
Price Target: $75
Current: $76.78
Upside: -2.32%
Jul 1, 2026
Reiterated: Buy
Price Target: $175
Current: $125.52
Upside: +39.42%
Jun 24, 2026
Reiterated: Buy
Price Target: $68
Current: $13.53
Upside: +402.59%
May 26, 2026
Maintained: Buy
Price Target: $44 → $62
Current: $42.60
Upside: +45.54%
May 13, 2026
Maintained: Buy
Price Target: $15
Current: $3.80
Upside: +294.74%
May 8, 2026
Maintained: Buy
Price Target: $14
Current: $2.01
Upside: +596.52%
May 7, 2026
Maintained: Buy
Price Target: $60
Current: $32.97
Upside: +81.98%
May 7, 2026
Maintained: Buy
Price Target: $14
Current: $1.71
Upside: +718.71%
Mar 13, 2026
Maintained: Buy
Price Target: $128 → $100
Current: $8.26
Upside: +1,110.65%
Mar 4, 2026
Reiterated: Buy
Price Target: $140
Current: $56.98
Upside: +145.70%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $17.23
Upside: +16.08%
Nov 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $36.74
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: $26
Current: $4.37
Upside: +494.97%
Feb 27, 2025
Maintained: Hold
Price Target: $20
Current: $29.45
Upside: n/a
Jan 3, 2025
Upgraded: Buy
Price Target: $45
Current: $24.19
Upside: n/a
Dec 11, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.37
Upside: n/a
Sep 21, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.72
Upside: n/a
Jul 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
May 31, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $16.76
Upside: n/a
May 15, 2020
Reiterated: Buy
Price Target: $9
Current: $1.30
Upside: n/a
Jul 20, 2018
Reiterated: Buy
Price Target: $115 → $123
Current: $34.21
Upside: n/a
Jul 13, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $0.9215
Upside: n/a
Dec 12, 2017
Reiterated: Buy
Price Target: $21 → $32
Current: $16.43
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: n/a
Current: $49.50
Upside: n/a
Aug 13, 2014
Reiterated: Buy
Price Target: n/a
Current: $13.71
Upside: n/a